UBS Group AG - PASITHEA THERAPEUTICS CORP ownership

PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F111. A total of 6 filers reported holding PASITHEA THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PASITHEA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$1100
-94.6%
0.00%
Q3 2022$01,849
+15.6%
0.00%
Q2 2022$01,599
+99.9%
0.00%
Q1 2022$0800
+1677.8%
0.00%
Q3 2021$0450.00%
Other shareholders
PASITHEA THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Warberg Asset Management LLC 311,183$20,0000.00%
Kepos Capital LP 334,600$22,0000.00%
ARMISTICE CAPITAL, LLC 1,000,000$65,0000.00%
UBS Group AG 1,599$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,803$1,0000.00%
View complete list of PASITHEA THERAPEUTICS CORP shareholders